Back to results
US 2024/0218036 A1Published application
Multi specific molecules
AssigneeAffilogic
InventorsOlivier KITTEN, Mathieu CINIER, Simon HUET
Life of this patent
Estimating the term…
Abstract
The invention relates to proteins having multi-specific binding abilities by fusion of an OB-fold variant, in particular from the Sac7d family, to the light or heavy chain of an antibody.
Claims24
A polypeptide comprising a modified antibody wherein at least one variant of a protein of the Sac7d family is fused to at least one heavy or light chain of the antibody, wherein the variant comprises between 4 and 20 or between 5 and 20 mutated residues in the binding site of the protein of the Sac7d family.
A genetic construct comprising a DNA sequence selected from:
- (a) a sequence coding for the heavy chain of an antibody fused at its 3′ end with a sequence coding for a variant of a protein of the Sac7d family;
- (b) a sequence coding for the heavy chain of an antibody fused at its 5′ end with a sequence coding for a variant of a protein of the Sac7d family;
- (c) a sequence coding for the light chain of an antibody fused at its 3′ end with a sequence coding for a variant of a protein of the Sac7d family;
- and
- (d) a sequence coding for the light chain of an antibody fused at its 5′ end with a sequence coding for a variant of a protein of the Sac7d family.
2 more elements
Dependencies are inferred from the claim text.